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Abstract
An array of schistosome endoproteases involved in the digestion of host hemoglobin to absorbable peptides has been described, but the
exoprotease responsible for catabolising these peptides to amino acids has yet to be identified. By searching the public databases we found
that Schistosoma mansoni and Schistosoma japonicum express a gene encoding a member of the M17 family of leucine aminopeptidases
(LAPs). A functional recombinant S. mansoni LAP produced in insect cells shared biochemical properties, including pH optimum for
activity, substrate specificity and reliance on metal cations for activity, with the major aminopeptidase activity in soluble extracts of adult
worms. The pH range in which the enzyme functions and the lack of a signal peptide indicate that the enzyme functions intracellularly.
Immunolocalisation studies showed that the S. mansoni LAP is synthesised in the gastrodermal cells surrounding the gut lumen. Accordingly,
we propose that peptides generated in the lumen of the schistosome gut are absorbed into the gastrodermal cells and are cleaved by LAP to
free amino acids before being distributed to the internal tissues of the parasite. Since LAP was also localised to the surface tegument it may
play an additional role in surface membrane re-modelling.
q 2004 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
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1. Introduction
Schistosomiasis is a chronic parasitic disease widespread
in tropical and sub-tropical regions such as Africa, the
Middle East, South America and South East Asia. In 1999,
the World Health Organisation estimated that 652 million
people were at risk, with 193 million actually infected and
about 20 million clinically ill from schistosomiasis (WHO,
1999). The disease is caused by blood flukes of the genus
Schistosoma, of which five species, Schistosoma mansoni,
Schistosoma japonicum, Schistosoma haematobium, Schis-
tosoma intercalatum and Schistosoma mekongi, are of
medical importance to humans (Engels et al., 2002; Ross
et al., 2002). Our laboratories have been particularly
interested in proteases that participate in proteolysis of
host hemoglobin, an essential source of nutrient for the
schistosome parasite. Maturing and adult schistosomes live
in the blood vessels of their human hosts where they feed on
red blood cells. The ingested red blood cells are lysed by
hemolysins within the oesophagus of the parasites and
hemoglobin that is released flows into caeca of the
schistosome (Dalton et al., 2004). Several proteolytic
enzymes participate in the progressive catabolism of
hemoglobin to amino acids that are subsequently utilised
in parasite metabolic processes. A model for this catabolic
process proposes that the initial cleavages of hemoglobin
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are performed by endopeptidases, including cathepsins B, L
and D, liberating short peptides that are subsequently
hydrolysed by exopeptidases into absorbable dipeptides and
amino acids (Brindley et al., 1997; Tort et al., 1999; Sajid
and McKerrow, 2002). Whereas we and others have
characterised the exopeptidase dipeptidyl peptidase I,
( ¼ cathepsin C), which is secreted from the parasite
gastrodermis into the gut and most likely is the enzyme
that cleaves dipeptides from fragments of host hemoglobin
(Hola-Jamriska et al., 1998, 1999, 2000), little is known of
the putative aminopeptidase that is crucial to the final stage
of liberating free amino acids.
Aminopeptidase activity has been demonstrated in
soluble extracts of various stages of the S. mansoni life
cycle (Auriault et al., 1982; Damonneville et al., 1982; Xu
and Dresden, 1986; Xu et al., 1988, 1990). Since the enzyme
displayed enhanced activity against synthetic substrates
containing an N-terminal leucine it has been termed leucine
aminopeptidase (LAP) (Auriault et al., 1982). The LAP
activity detected in schistosomula and adult extracts was
shown to be immunogenic during infections since the
enzyme was reactive with antibodies in the serum of
infected rats and humans (Auriault et al., 1982; Damonne-
ville et al., 1982; Doenhoff et al., 1988). LAP activity is also
expressed by schistosome eggs and has been implicated in
the emergence of the schistosome miracidium since
hatching can be blocked by bestatin, a general inhibitor of
aminopeptidases (Xu and Dresden, 1986; Xu et al., 1988,
1990).
In this study, we isolated a cDNA encoding an S. mansoni
aminopeptidase that is a member of the metalloprotease
M17 family of LAPs (Strater and Lipscomb, 1998). Our
characterisation of the recombinant and native LAP shows
that it is predominantly expressed in the gastrodermis of the
adult worms, and indicates that we have identified the
schistosome enzyme responsible for the final stage in
the catabolism of host hemoglobin. We discuss these
findings in the context of our model of hemoglobin
proteolysis in these blood-feeding parasites, and of previous
reports of aminopeptidase activity in schistosomes.
2. Materials and methods
2.1. Parasite extracts, protein preparations and infection
sera
Soluble extracts of S. mansoni cercariae and adult worms
and S. japonicum adult worms were prepared in phosphate
buffered saline (PBS, pH 7.3) after three freeze thaw cycles
and sonication cycles on ice as described previously (Dalton
et al., 1996). Insect cell-expressed S. mansoni asparaginyl
endopeptidase (Sm32) (Brindley et al., 1997; Tort et al.,
1999) was purified in our laboratory (Stack, Dalton and
Doyle, unpublished). Pig kidney LAP was obtained from
Sigma Chemical Co (Dorset, Poole).
2.2. Fluorogenic substrate assay and fluorographic gel
analysis for the detection of aminopeptidase activity
Aminopeptidase activity of S. mansoni or S. japonicum
soluble extracts, porcine kidney LAP or recombinant
S. mansoni LAP was measured using the fluorogenic pepti-
dyl substrates L-leucine (Leu)-7-amido-4-methylcoumarin
hydroxide (NHMec), L-alanyl (alanine)-NHMec, L-tyrosyl
(tyrosine)-NHMec and L-prolyl (proline)-NHMec (Sigma).
The assays were carried out by incubating samples in a
reaction mix of 10 mM fluorogenic peptidyl substrate,
0.5 mM MgCl2 and 0.1 M Tris–HCl (pH 8.5) in a final
volume of 1 ml at 37 8C for 30 min as described before
(Gavigan et al., 2001). A standard curve was prepared using
0–10 mM NHMec and enzyme units presented nmol
NHMec released/min/ml.
For the activation/inhibition studies, the enzyme was
incubated with the divalent cations MgCl2, MnCl2 and
ZnCl2, the metal chelating reagents 1,10-phenanthroline,
and N,N-ethylenediaminetetraacetic acid (EDTA) or the
specific aminopeptidase inhibitor bestatin at 37 8C for
10 min prior to addition of the fluorogenic peptidyl substrate
to the assay mix and incubation for 30 min. The pH profile
was determined by incubating enzyme in 0.1 M Tris–HCl
buffers ranging from pH 6.75 to 9.4.
To characterise aminopeptidase activity in gels soluble
extracts of adult S. mansoni and S. japonicum, recombinant
S. mansoni LAP and pig kidney LAP were separated on 10%
native polyacrylamide gels, which were then washed in
0.1 M Tris–HCl (pH 8.5) containing 0.5 mM MgCl2 and
incubated for 10 min in the same buffer containing 50 mM
L-leucine-NHMec as described (Curley et al., 1994; Acosta
et al., 1998). Fluorescent bands representing enzymes with
LAP activity were visualised under UV light and
photographed.
2.3. Identification and analysis of the cDNA encoding
schistosome leucine aminopeptidase
A cDNA encoding an S. mansoni aminopeptidase
(GenBank U83906) was discovered by searching the public
databases with the peptide sequence NTDAEGRL that
represents the conserved active site region of aminopepti-
dases (Kim and Lipscomb, 1993; Strater and Lipscomb,
1998). Analysis of the S. mansoni aminopeptidase sequence
was performed using sequence retrieval system (SRS), Blast
tools, and MEROPS at http://merops.sanger.ac.uk. The Bos
taurus LAP (bovine lens LAP, BlLAP) sequence and
structural data were employed to locate catalytic domains
and critical active site residues (Kim and Lipscomb, 1993;
Taylor, 1993). The phylogenetic relationship between
selected LAPs of the M17 family of aminopeptidases was
examined using selected C-terminal domains only.
Sequence similarities within the catalytic domains were
determined using the BLAST algorithm and the selected
sequences were then aligned using the ClustalX 1.81
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program (Thompson et al., 1997). The PHYLIP tree was
calculated using the bootstrapping method, with the number
of bootstrapping trials set at 1000 as recommended. The
program also corrected for multiple substitutions.
2.4. Construction of cDNA expression vector
Primers were designed to amplify the full-length cDNA
encoding S. mansoni LAP using the DNA sequence
information deposited in GenBank (accession no. U83906)
as follows: Forward (50-GCGGCCTCGAGATGAGC
GTTGTCACTCCCGTGTTCCCG-30) and Reverse (50-
GCCGCTCTAGATTAGTGGTGGTGGTGGTGGTGGG
GCCCCTTGAAACTTAATCG-30). The forward and
reverse primers incorporated the restriction sites Xho I and
Xba I (underlined), respectively. The forward primer
incorporated a start codon (bold) which was not present in
the published sequence (see Section 3) and the reverse
primer contained a sequence encoding a His6 tag (double
underlined) and a stop codon (also bold). Amplification of
the LAP cDNA from an S. mansoni cDNA library was
performed under the following conditions: initial denatura-
tion (94 8C, 5 min), followed by 30 cycles of denaturation
(94 8C, 1.5 min), annealing (55 8C, 1.5 min) and primer
extension (72 8C, 1.5 min), followed by a final extension
step (72 8C, 7 min). PCR products were cloned into pGem-T
vector (Promega, USA), and the LAP gene subsequently
excised from the plasmid using restriction endonucleases
Xho I and Xba I and cloned into the baculovirus expression
transfer vector pBlueBac4.5 (Invitrogen). The insert of the
pBlueBac4.5 construct was sequenced to confirm orien-
tation and identity of the LAP cDNA.
2.5. Production and purification of recombinant S. mansoni
LAP in baculovirus expression vector system
Spodoptera frugiperda (Sf9) insect cells (Invitrogen)
were transformed with pBlueBac4.5 plasmid construct
incorporating the S. mansoni LAP cDNA as previously
described (Ennis et al., 2001). Cell suspensions were lysed
in the presence of 0.05% (v/v) Tweenw 20 (Sigma)
detergent in 50 mM NaH2PO4, 300 mM NaCl, and 10 mM
imidazole (pH 8.0, lysis buffer), and then incubated on ice
for 30 min. The cell lysate was centrifuged at 14,000 £ g for
30 min and the supernatants passed over a 1 ml Ni-NTA
resin column, and the column washed with five volumes of
50 mM NaH2PO4, 300 mM NaCl, and 20 mM imidazole
(pH 8.0). Bound protein was eluted using 250 mM
imidazole in 50 mM NaH2PO4 and 300 mM NaCl (pH
8.0). The production and purification of recombinant
S. mansoni LAP was monitored by Coomassie Blue-stained
SDS-PAGE (Dalton et al., 1996). Protein concentrations
were determined using a bicinchoninic protein assay kit
(Pierce, Rockford, IL) with bovine serum albumin
(0–2 mg ml21) as protein standard.
2.6. Preparation of polyclonal antiserum to S. mansoni LAP
(anti-SmLAP)
Polyclonal antiserum to S. mansoni LAP was obtained by
immunising a rabbit four times at 3-week intervals, sub-
cutaneously, with purified recombinant protein (50 mg)
formulated in Freunds Complete or Incomplete adjuvant.
Serum was obtained 10 days after the final immunisation.
2.7. Immunoblotting
Soluble S. mansoni and S. japonicum extracts (10 mg)
and purified recombinant LAP (2.0 mg) were resolved on
12% reducing SDS-PAGE gels and then transferred to
nitrocellulose membrane. The membranes were blocked in
5% (w/v) milk powder/PBS plus 0.05% (v/v) Tweenw 20
(PBST) for 1 h and then probed with rabbit anti-S. mansoni
LAP serum (1:6000) or pre-immunisation serum (control)
for 1 h at room temperature. Bound antibody was visualised
using peroxidase-conjugated goat anti-rabbit IgG (1:1000)
and diaminobenzidine/H2O2 (Sigma, Dorset, UK) as the
chromogenic substrate (Brady et al., 1999a,b).
2.8. Confocal scanning laser microscopy
Adult S. mansoni were flat-fixed in 4% paraformalde-
hyde (PFA) in PBS (pH 7.2) for 1 h and then free-fixed for a
further 3 h at 4 8C. They were washed in antibody diluent
(AbD: PBS with 0.1% bovine serum albumin, 0.3% Triton
X-100 and 0.1% sodium azide) for 24 h before being
incubated for 72 h at 4 8C in anti-SmLAP serum (diluted
1:500) and subsequently washed in AbD (24 h, 4 8C).
Specimens were incubated for 48 h in anti-rabbit IgG
(1:100) conjugated to tetramethylrhodamine isothiocyanate
(TRITC) for visualisation of binding sites. Specimens were
washed again in AbD, incubated for 24 h in phalloidin-
fluorescein isothiocyanate (FITC) (as a counterstain that
binds F-actin) and, after a final wash in AbD, were mounted
in PBS/glycerol (1:9) containing 2.5% 2,4-diazabicylco
2.2.2 octane for confocal microscopic examination (Leica
TCS-NT; Leica Microsystems, Milton Keynes, UK).
Immunocytochemical controls included omission of pri-
mary antiserum and replacement of the primary antiserum
with pre-immune serum.
3. Results
3.1. Classification of the schistosome aminopeptidase based
on primary sequence structure
By searching the public databases with the peptide
sequence NTDAEGRL that represents the conserved active
site region of aminopeptidases (Kim and Lipscomb, 1993;
Strater and Lipscomb, 1998), we located a cDNA that
encodes an S. mansoni aminopeptidase (GenBank U83906).
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Sequence alignment and phylogenetic analyses using the
amino acid sequence deduced from this cDNA revealed that
the enzyme is a member of the M17 family of LAPs (Strater
and Lipscomb, 1998). The S. mansoni LAP sequence is
most closely related to an S. japonicum expressed sequence
tag (EST) sequence (accession no. AF300423); the two
proteins share 85% amino acid identity suggesting that they
are orthologous enzymes (i.e. they perform the same
function in these two discrete, schistosome species). The
recent appearance in GenBank of .40,000 cDNAs, which
may include the complete transcriptome of the adult stage of
S. japonicum (Hu et al., 2003), enabled us to re-interrogate
the public databases with accession nos. U83906 and
AF300423. Although this analysis located over 80
additional entries encoding partial S. japonicum LAPs (not
shown), each of these showed complete identity to the
original EST sequence. This in turn supported the notion
that a single copy gene encodes the LAP characterised here.
The relationship between the S. mansoni and S.
japonicum LAPs and other members of the M17 family
was investigated by comparing the sequence similarities in
the conserved C-terminal domain (see below). The schisto-
some LAPs are most similar to an uncharacterised insect
LAPs of Aedes gambiae (accession no. XP_311765) and
Drosophila melanogaster (accession no. NP_650318).
Remarkably, only one helminth LAP sequence with close
similarity to the schistosome LAP was detected in the
databases; this sequence is one of two LAP genes expressed
by the nematode Caenorhabditis elegans (accession no.
Q27245; 41 and 39% amino acid identity to the S. mansoni
and S. japonicum LAPs, respectively). The more diverged
C. elegans LAP (accession no. P34629; 12 and 11% amino
acid identity, respectively, does not seem to have an
orthologue in the schistosome genome, but resides in the
clade that includes LAPs from several species of Leishma-
nia. LAP members of the M17 family from the flowering
plants Arabidopsis thaliana, Lycopersicon esculentum and
Solanum tuberosum form a discrete and more distant clade
from the schistosome LAPs (Fig. 1).
An alignment of the primary sequence of S. mansoni and
S. japonicum LAPs with the A. gambiae, D. melanogaster
and C. elegans sequences is presented in Fig. 2. The amino
acids of the five sequences were 22.18% identical, 18.11%
strongly similar and 11.65% weakly similar (total overall
similarity 52%). LAPs consist of a two-domain structure, a
less conserved N-terminal domain and a more conserved C-
terminal domain that contains the catalytic residues. As
expected, the schistosome and other sequences show greater
conservation in this catalytic C-terminal domain (Fig. 2).
LAP are metallo-proteases and require the binding of two
zinc ions that are pentahedrally coordinated within each
active site. These metal ions act as nucleophiles and are
essential for enzymatic activity. Accordingly, the residues
that bind these zinc ions are highly conserved between all
members of the M17 family of LAP enzymes including the
schistosome LAPs. Residues Asp 289, Asp 367 and Glu 369
bind zinc 1, while Asp 289, Lys 284, Asp 307 and Glu 369
bind zinc 2. The residues Lys 296 and Arg 371 are also
involved in the catalytic mechanism by acting as an
electrophile and proton donor, respectively, and are thus
also conserved in all LAPs.
3.2. Functional expression of recombinant S. mansoni
LAP in insect cells
The cDNA sequences encoding the S. mansoni (U83906)
and S. japonicum (AF300423) LAPs both lack start codons
and are therefore incomplete. However, by analysing the
more recent S. japonicum sequence entries (Hu et al., 2003),
we completed the 50 end of the LAP gene of this species and
identified the start methionine. The protein sequence of the
S. japonicum LAP (AF300423) was missing 26 NH2-
terminal amino acids (see accession no. BU795916 for 50
end of S. japonicum cDNA at http://schistosoma.chgc.sh.
cn). By comparison, we found that the orthologue in
S. mansoni LAP (U83906) was apparently missing only one
amino acid, the start methionine. Accordingly, to express
enzymatically active S. mansoni LAP in insect cells, we
introduced a start codon (ATG) at the 50 end of the S. manoni
cDNA by incorporating it into the forward primer used in
the amplification of the gene from the cDNA library.
(However, screening of the S. mansoni EST data recently
published by Verjovski-Almeida et al. (2003) revealed that
the S. mansoni sequence was missing three NH2-terminal
amino acids—see accession nos. MS1-0068T and MS1-
0128T).
S. mansoni LAP was purified from recombinant baculo-
virus-infected insect cell extracts by single-step affinity
chromatography on Ni-NTA agarose and was resolved as a
57.5 kDa band following SDS-PAGE. The predicted
molecular weight of the protein is 56,551.3 Da; the
additional molecular weight of the recombinant protein is
contributed by additional amino acids associated with the
vector and the His6 tag (Fig. 3A). Purified recombinant
S. mansoni LAP exhibited a specific activity of
1302 U mg21 protein against the diagnostic LAP substrate,
L-Leu-NHMec. In contrast, the specific activity of the LAP
in the soluble extracts of adult S. mansoni and S. japonicum,
was 1.4 U mg21 protein and 1.45 U mg21 protein,
respectively.
Recombinant S. mansoni LAP was resolved by native
polyacrylamide gels alongside samples of soluble
S. mansoni extract, soluble S. japonicum extract and porcine
kidney LAP (Fig. 3B). The gels were incubated in the
substrate L-leu-NHMec for 10 min to detect LAP activity. A
single band representing LAP activity was visualised under
UV light in the recombinant LAP sample and this co-
migrated with a single band of activity detected in the
S. mansoni and S. japonicum extracts. The positive control,
porcine kidney LAP, was also visualised as a single band
although this enzyme migrated further into the gel.
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3.3. Immunological detection of S. mansoni LAP
in parasite extracts
Rabbit antiserum prepared against recombinant
S. mansoni LAP detected a single polypeptide in S. mansoni
extracts that co-migrated at ,57.5 kDa with the recombi-
nant SmLAP (Fig. 4A). A single protein was also detected in
S. japonicum extracts but this migrated faster, at approxi-
mately 52 kDa. LAP is also expressed in S. mansoni
cercariae and it migrated as a similar sized protein to the
adult form (Fig. 4B).
3.4. Physico-chemical properties of recombinant
S. mansoni LAP
Recombinant S. mansoni LAP activity displayed a
preference for a neutral/slightly alkaline (pH 6.5–9.4)
environment. Enzyme activity was optimal at pH 8.25 and
was not detectable below pH 6.5 (Fig. 5A). This pH profile
correlated closely with the profile for LAP activity in
soluble extracts of S. mansoni and S. japonicum that also
exhibited optimal activity at pH 8.25. LAP members of the
M17 family are metalloenzymes and thus require
Fig. 1. The phylogenetic relationship between S. mansoni and S. japonicum LAP and various other members of the M17 family. Schistosoma mansoni LAP is
most closely related to S. japonicum LAP. In turn the schistosome LAPs are most similar to the insect LAPs from the A. gambiae genome sequencing project
(accession no. XP_311765) and D. melanogaster (accession no. NP_650318). Of the two LAP genes expressed by C. elegans, the schistosome LAPs are most
similar to LAP-2 (accession no. Q27245). Caenorhabditis elegans LAP-1 resides in a clade that includes the LAP genes of the protozoan parasitic Leishmania
species, Leishmania major (accession no. AF424693), Leishmania donovani (accession no. AF424692) and Leishmania mexicana amazonensis (accession no.
AF424691). Plant LAP members of the M17 family A. thaliana (accession no. P30184), Solanum tuberosum (accession no. P31427), L. esculentum Ap-1
(accession no. Q10712) and L. esculentum Ap-2 (accession no. Q42876) form a discrete and more distinct clade from the schistosome LAP genes.
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Fig. 2.
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the presence of metal cations to maintain enzyme activity
and stability (Kim and Lipscomb, 1993; Taylor, 1993;
Strater and Lipscomb, 1998). An analysis of the metal ion
requirement for S. mansoni LAP showed that manganese
and magnesium ions enhanced recombinant LAP activity
2–4 fold. LAP activity in soluble extracts of S. mansoni and
S. japonicum was likewise enhanced by the addition of these
metal ions. In contrast, zinc cations reduced the activity of
recombinant LAP, S. mansoni and S. japonicum by as much
as 94, 84 and 31%, respectively. The metal chelators EDTA
and 1,10-phenanthroline and the aminopeptidase inhibitor
bestatin were all inhibitory for both recombinant and native
schistosome LAP (Table 1).
Recombinant S. mansoni LAP exhibited a marked
preference for Leu when compared to Ala, Tyr and Pro in
keeping with its classification as a M17 LAP (Fig. 5B). The
LAP activity in S. mansoni and S. japonicum soluble
extracts shows a similar substrate profile. Porcine kidney
LAP also demonstrated a preference for Leu but its relative
activity against Ala and Tyr differed from the schistosome
enzyme. Characteristically, these aminopeptidases do not
cleave the bulky hydrophobic residue Pro (Kim and
Lipscomb, 1993; Taylor, 1993; Strater and Lipscomb,
1998).
3.5. Immunolocalisation of S. mansoni LAP by confocal
scanning laser microscopy
LAP-immunoreactivity was predominately associated
with the alimentary tract. Strong immunoreactivity sur-
rounded the subapical mouth, with staining localised below
the musculature of the oral sucker (Fig. 6A); no staining was
associated with the ventral sucker (Fig. 6B). Within the
alimentary tract itself, the oesophagus was immunonegative
while strong staining was observed immediately distal to the
oesophageal opening of the paired gut caeca (Fig. 6B and
C). LAP-immunoreactivity was associated with the syncitial
gastrodermis and filled the lumen of the anterior regions of
the paired gut caeca (Fig. 6B–D). Staining within the lumen
and in the gastrodermis decreased posteriorly becoming
undetectable in the distal third of the worm (Fig. 6E). LAP-
immunoreactivity was considerably stronger within the gut
Fig. 2. Alignment of LAP from S. mansoni (SmLAP) with S. japonicum LAP (SjLAP), Anopheles gambiae LAP (AgLAP, accession no. XP_311765), D.
melanogaster LAP (DmLAP, accession no. NP_650318) and LAP-2 from C. elegans (CeLAP-2, accession no. Q27245). This alignment indicates the
conserved sites (*) among the five sequences (22.18% identical). Of the sequences, 18.11% are strongly similar (:) and 11.65% are weakly similar (.). All five
sequences are of similar length (SmLAP, 523 residues; SjLAP, 521 residues; AgLAP, 516 residues; DmLAP, 508 residues; CeLAP, 522 residues), although it
must be noted that AgLAP is incomplete at the N-terminus. Each LAP subunit is a two-domain structure, consisting of an N-terminal domain and a catalytic C-
terminal domain. The sequences are more conserved in the catalytic C-terminal domain of each subunit (highlighted in bold). Active LAP requires the binding
of two zinc ions that are pentahedrally coordinated within each active site. Zinc 1 is bound by Asp 289, Asp 367 and Glu 369 (underlined). Zinc 2 is bound by
Asp 289, Lys 284, Asp 307 and Glu 369 (underlined). These residues are highly conserved between all members of the M17 family of LAP enzymes. Lys 296
and Arg 371 (double underlined) are also involved in catalysis acting as an electrophile and proton donor, respectively.
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of females than males. A distinct layer of sub-tegumental
immunostaining that became progressively more intense
posteriorly was observed along the length of the body
(Fig. 6E and F). In contrast to LAP immunostaining in the
gut, the sub-tegumental staining was stronger in males than
females. No staining was observed in the reproductive
system. All controls gave negative results (Fig. 6D, inset).
4. Discussion
Sequence alignments and phylogenetic analyses revealed
that the schistosome aminopeptidases encoded by the
cDNAs described were members of the clan MF that
contains only one family, M17, also known as the leucyl
aminopeptidases (LAPs) (Strater and Lipscomb, 1998).
Whereas LAPs have been identified in many organisms, to
date no M17 aminopeptidase has been characterised from a
parasitic worm. Aminopeptidase activity, however, has
been detected in parasite extracts from schistosomes
(Auriault et al., 1982; Damonneville et al., 1982; Xu and
Dresden, 1986; Xu et al., 1988, 1990; Doenhoff et al., 1988),
Fasciola hepatica (Acosta et al., 1998; Piacenza et al.,
1999) and Ascaris suum (Rhoads and Fetterer, 1998). The
well-characterised Haemonchus contortus aminopeptidase,
H11 (accession no. AJ249941) (Newton, 1995), differs from
the aminopeptidases investigated here in that it is a
membrane bound, microsomal enzyme of Clan MA(E),
Family M1. The schistosome LAPs are most closely related
to LAPs of the mosquito A. gambiae and the fruitfly
D. melanogaster, but the function of these enzymes is
unknown. More interestingly, we found only one helminth
sequence in the public databases that was related to the
schistosome LAP, namely one of the two LAPs of the free-
living nematode C. elegans, accession no. Q27245, but this
enzyme is also uncharacterised. Schistosomes apparently do
Fig. 3. Purification of functionally active recombinant S. mansoni LAP
expressed in insect cells. (A) Samples from the purification were analysed
on 12% reducing SDS-PAGE. Lane 1, protein molecular size markers;
Lane 2, soluble extract of insect cells infected with recombinant
baculovirus encoding SmLAP; Lane 3, soluble extract of uninfected insect
cells; Lane 4, Ni NTA-agarose-purified recombinant SmLAP (0.7 mg). (B)
Soluble extracts of adult schistosome and recombinant SmLAP were
separated in 10% native PAGE and subjected to direct fluorogenic substrate
analysis by probing with L-leu-NHMec. Lane 1, soluble extracts of S.
mansoni; Lane 2, soluble extracts of S. japonicum; Lane 3, purified
recombinant SmLAP; Lane 4, porcine kidney LAP.
Fig. 4. Immunoblot identification of schistosome LAP in parasite extracts.
Somatic extracts from S. japonicum, S. mansoni and recombinant LAP were
resolved using 12% SDS-PAGE, blotted to nitrocellulose membrane and
probed with polyclonal antibodies prepared against S. mansoni recombinant
LAP. (A) Lane 1, molecular size markers; Lane 2, soluble extracts of adult
S. mansoni; Lane 3, soluble extracts of adult S. japonicum; Lane 4, purified
recombinant SmLAP. (B) Lane 1, molecular size markers; Lane 2, soluble
extracts of adult S. mansoni; Lane 3, soluble extracts of S. mansoni cercaria.
Pre-immune rabbit sera did not bind to any proteins in parasite extracts (not
shown).
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not express the orthologue of the second aminopeptidase
(P34629) of C. elegans.
LAPs consist of two structurally unrelated domains. The
NH2-terminal domain is not conserved amongst LAPs,
varies in length among members, and does not exhibit
identity with other proteins. In contrast, the COOH-terminal
domain contains the catalytic and the zinc-binding residues
and is structurally related to carboxypeptidases A and T
(Clan MC) (Kim and Lipscomb, 1993; Taylor, 1993; Strater
and Lipscomb, 1998). The substrate and zinc binding sites
are well conserved in the M17 family and consequently its
members from prokaryotes, plants and animals display
similar activity profiles (Strater and Lipscomb, 1998). These
sites are conserved in S. mansoni and S. japonicum LAPs,
and recombinant S. mansoni LAP displayed biochemical
properties consistent with those of other M17 family
peptidases. Specifically, recombinant S. mansoni LAP had
a marked substrate preference for NH2-terminal leucine
residues, a requirement for metal ions for activity and a
neutral to weakly alkaline pH optimum.
By fluorogenic substrate gel analysis, we detected a single
aminopeptidase activity in extracts of adult S. mansoni and
S. japonicum suggesting that the enzyme is the major
aminopeptidase activity in these preparations. In support of
this, recombinant SmLAP exhibited a similar biochemical
profile to the LAP activity in the parasite extracts. Using
antibodies prepared against the recombinant SmLAP we
identified the enzyme as a single protein in soluble extracts of
mixed adult S. mansoni at ,57.5 kDa, which is slightly
higher than its predicted molecular mass of 56,739.4 kDa
from analysis of the primary sequence. The S. japonicum
LAP also resolved as a single protein, but migrated at
approximately 52 kDa which is lower than its predicted mass
of 56,210.68 kDa. The enzyme of each schistosome,
however, co-migrated as single bands in native polyacryl-
amide gels and their specific activities in the soluble extracts
were similar (S. mansoni LAP 1.4 U mg21 protein and
S. japonicum LAP 1.45 U mg21 protein). Disparities in the
predicted and apparent molecular sizes of the S. mansoni
LAP may be due to post-translational glycosylation which
would tend to cause proteins to migrate slower in gels but this
Fig. 5. Comparison of the biochemical properties of recombinant SmLAP
with the LAP activity in soluble extracts of adult schistosomes. (A) The
effect of pH on LAP activity of purified recombinant SmLAP (x) soluble
extracts of adult S. mansoni (V) and soluble extracts of adult S. japonicum
(B). (B) The relative activity of recombinant SmLAP, soluble extracts of
adult S. mansoni, soluble extracts of adult S. japonicum and porcine kidney
against the fluorogenic substrates L-leu-NHMec (hatched bar), L-ala-
NHMec (black bar), L-tyr-NHMec (white bar) and L-pro-NHMec (no
activity). The hydrolysis of substrates was measured as a percentage of the
optimal substrate L-leu-NHMec.
Table 1
Effect of divalent metal cations, chelators and inhibitors on recombinant S. mansoni leucine aminopeptidase (LAP) and LAP activities in soluble extracts of
S. mansoni and S. japonicum
Recombinant S. mansoni LAP S. mansoni soluble extract S. japonicum soluble extract
Control (no treatment) 100 100 100
Divalent cations
MnCl2 (0.05 mM) 139.8 ^ 0.5 380.4 ^ 1.5 442.1 ^ 2.9
MnCl2 (0.5 mM) 87.6 ^ 1.9 236.4 ^ 0.2 364.6 ^ 1.6
MgCl2 (0.05 mM) 186.4 ^ 1.5 299.7 ^ 1.6 146.3 ^ 5.6
MgCl2 (0.5 mM) 205.0 ^ 12.1 409.0 ^ 1.0 350.1 ^ 16.1
ZnCl2 (0.05 mM) 24.7 ^ 0.3 29.1 ^ 0.1 88.9 ^ 4.9
ZnCl2 (0.5 mM) 6.0 ^ 0.5 15.6 ^ 0.1 69.4 ^ 0.6
Metal chelators
EDTA (5 mM) 51.5 ^ 0.6 36.7 ^ 0.7 101.9 ^ 1.5
o-Phenanthroline (5 mM) 28.6 ^ 0.6 56.4 ^ 0.2 38.5 ^ 0.6
Inhibitor
Bestatin (50 mM) ,0.05 ,0.05 30.2 ^ 0.1
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Fig. 6. Confocal scanning laser micrographs of S. mansoni immunostained for LAP (red) and counterstained for filamentous actin with phalloidin-FITC
(green). (A) Anterior of male showing pulses of LAP-immunoreactivity (arrow) lying beneath the musculature of the oral sucker (os). (B) Feeding and
attachment apparatus of male illustrating the lack of immunostaining in the oesophagus (oe) in contrast to the strong staining in the paired limbs of the intestine
(it). No staining is associated with the ventral sucker (vs). os, oral sucker. (C) Intense immunoreactivity invests the intestinal caeca (it) of this female with a
clear demarcation in staining between the intestine and the oesophagus (oe). vs, ventral sucker. For the most part immunoreactivity to LAP was considerably
stronger in the gut of females than males. (D) Higher powered image of the intestine with strong immunostaining in the gut lumen (gl) and syncytial cell bodies
(cb) of the gastrodermis. Insert: control specimen (showing region of gynaecophoric canal) stained with pre-immune serum illustrating an absence of unspecific
staining within the gut (arrows). (E) LAP-immunoreactivity becomes progressively weaker in the intestine (it) moving posteriorly, while sub-tegumental
staining (arrows) increases in intensity. (F) High powered image of immunoreactivity (arrows) lying below the body wall musculature (bw) in the posterior
third of a male. This staining lying beneath the tegument/body wall was noted to be stronger in males than in females.
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would not account for the faster migrating S. japonicum LAP.
Isoelectric focusing techniques resolved three S. mansoni
aminopeptidase activities (Damonneville et al., 1982) that
may result from heterogeneity in the levels of glycosylation.
The LAPs of S. mansoni and the S. japonicum both possess
one potential N-glycosylation site, Asp-497 in S. mansoni
LAP and Asp-166 in the S. japonicum orthologue.
The S. mansoni LAP was predominantly expressed by
gastrodermal cells lining the caecum where digestion of host
haemoglobin takes place following the lysis of host red
blood cells in the oesophagus. This localisation implies that
LAP is involved in this process of digestion, and the greater
intensity of staining in female worms compared with males
correlates with the higher consumption of red blood cells in
the former (Brindley et al., 1997; Tort et al., 1999).
However, pH profile studies showed that the recombinant
and native LAPs are active in the pH range 6.5–9.0 (optimal
at pH 8.25) and inactive below pH 6.5 which suggest that
the enzyme may not function efficiently in the slightly acidic
environment of the gut lumen. Endopeptidases known to be
involved in hemoglobin catabolism, including cathepsin L1,
cathepsin L2 and cathepsin D, are all optimally active at low
pH (,5.0) (Brindley et al., 1997; Tort et al., 1999) while
cathepsin B1 is optimally active at pH ,6.5 (Sajid et al.,
2003). In addition, the exopeptidase, cathepsin C (dipepti-
dylpeptidase I) is optimally active at pH 4.0–5.0 (Hola--
Jamriska et al., 1998, 1999, 2000). In contrast to all these
peptidases, the SmLAP does not possess a signal peptide
necessary for passage into the secretory pathway and
therefore the enzyme most likely functions intracellularly.
These observations allow us to hypothesise on the final
stages of hemoglobin digestion in our model—short
peptides generated by the action of various endopeptidases
in the gut lumen are transported into the cytosol of
gastrodermal cells surrounding the gut lumen where they
are hydrolysed to free amino acids by LAP. Free amino
acids could subsequently distribute to various schistosome
tissues by simple diffusion or via specific amino acid
permeases (Dalton et al., 2004).
SmLAP was localised to other schistosome tissues,
including sub-tegumental regions, suggesting that the
enzyme plays an additional role(s) in schistosome biology.
The specific role of LAPs in plant and animal tissues is
not known but their expression in different tissues is
consistent with their role in a variety of processes such as
the maturation of proteins, the terminal degradation of
proteins and the metabolism of secreted regulatory
molecules (Strater and Lipscomb, 1998). Since they are
exopeptidases, they must function in degrading either
biologically active small peptides, such as hormones, or
large polypeptides in concert with endopeptidases (Strater
and Lipscomb, 1998; Gavigan et al., 2001). In this
context, it is of interest to note that cathepsin L1 (Dalton
et al., 1996; Brady et al., 1999a,b) and cathepsin B2
(Caffrey et al., 2002) endoproteases have also been
localised to the tegument and hence it is plausible that
a multi-enzymatic degradation process, similar to that
described for hemoglobin digestion in the gut, also occurs
in this tissue. The up-regulation of tomato LAP expression
is associated with mechanical wounding or infestation and
may be part of a protein turnover or tissue repair
mechanism (Gu et al., 1999). Given that the schistosome
surface membrane is in constant flux, it is possible that
cathepsin L1, cathepsin B2 and LAP work in concert in
the dismantling, degradation and turnover of the protein
components of the membrane.
SmLAP activity was also detected in soluble cercarial
extracts, consistent with reports of LAP activity in
schistosomula and adults (Auriault et al., 1982; Damonne-
ville et al., 1982). The process of membrane turnover and
repair is critical to the transformation of the infective free-
living cercaria to the schistosomule, and soon after skin
penetration, the schistosomule begins to feed on host
blood. Therefore, the function of the LAP in these
juvenile stages of schistosomes may be similar to that in
the adult worms, i.e. hemoglobin digestion and surface
membrane re-modelling. Another function of LAP may be
facilitating hatching since LAP activity was associated
with the miracidial stage and hatching was prevented by
the general aminopeptidase inhibitor bestatin. However,
two LAP activities, one membrane-associated and one
soluble, were detected in egg homogenates and hatching
fluid (Xu and Dresden, 1986; Xu et al., 1988, 1990). The
membrane-associated aminopeptidase was further charac-
terised and shown to migrate as a single band at 140 kDa
following reducing SDS-PAGE (Xu et al., 1990) and is
clearly not the enzyme described here. Accordingly,
further work is required to elucidate whether the
57.5 kDa LAP, a different soluble LAP or the 140 kDa
membrane-associated aminopeptidase, is responsible for
miracidial hatching.
Finally, schistosome LAP is worthy of investigation
as a vaccine candidate given its potentially crucial roles
in parasite nutrition and maintenance of tegumental
structure, and its expression in the early invasive stages
of the parasite. Of relevance in this regard is the recent
finding of significant protection in sheep against the
related fluke parasite F. hepatica by vaccination with
purified Fasciola LAP alone or in combination with a
cathepsin L protease (Piacenza et al., 1999). Since the
recombinant enzyme is available in active enzymatic
conformation, the vaccine potential of the schistosome
LAP can now be evaluated.
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